Combatting Bacterial
Resistance in Europe


Antimicrobial resistance is a growing problem worldwide, and with few new drugs making it to the market, there is an urgent need for new medicines to treat resistant infections.
Read more

Join the European Antibiotic Awareness Day Event Online!

11/18/2016: The European Center for Disease Prevention and Control, in coordination with the European Commission, is holding an online EU-level launch event to mark the 9th European Antibiotic Awareness Day (EAAD).
Read more

Good Clinical Practice

To assure a European research infrastructure performing high-quality clinical trials related to antibiotic resistance, all CLIN-Net participants are required to comply with ‘Good Clinical Practices’ (GCP).
Register now

Latest blog


Join the European Antibiotic Awareness Day Event Online!


The European Center for Disease Prevention and Control, in coordination with the European Commission, is holding an online EU-level launch event to mark the 9th European Antibiotic Awareness Day (EAAD). The EAAD is an annual European public health initiative that takes place on the 18th of November to raise awareness about the threat to public health of antibiotic resistance and prudent antibiotic use.

The event will be web streamed and ECDC will be tweeting live. Everyone can join by sending questions from their personal or corporate accounts to @EAAD_EU, using the hashtag #EAAD2016.  Read more on the site of the European Antibiotic Awareness Day.    

Titled "The Future is Now", will take place today,18 November from 09:30 to 13:00 in Brussels. Speakers such as Dr Vytenis Andriukaitis (EU Commissioner for Health and Food Safety), Mr Martin Seychell (Deputy Director-General for Health and Food Safety), Dr Ruxandra Draghia-Akli (Deputy Director-General for Research and Innovation), Dr Danilo Lo Fo Wong (Programme Manager, control of antimicrobial resistance, World Health Organization Regional for Europe) will take part, together with representatives from the European Medicines Agency, the European Food Safety Authority, and ECDC.  

The planned interventions will not only present the current situation and future steps at EU level, but will also aim at highlighting how resistance to antibiotics is affecting our lives today and what can be done by different sectors to ensure that antibiotics remain effective.


Antibiotic Awareness in the Netherlands

Europe recognizes and acknowledges that the Netherlands do a fantastic job controlling antibiotic resistance. How do they do it? In his latest blog, Marc Bonten gives 3 reasons that did NOT contribute to the Dutch  success.


Read Marc’s blog on here.



Da Volterra and The Medicines Company Join COMBACTE-NET

Today the Innovative Medicines Initiative (IMI)-funded New Drugs 4 Bad Bugs (ND4BB) project COMBACTE-NET announces that two new pharmaceutical companies, Da Volterra and The Medicines Company, have joined the project as partners. Together with the existing partners the new partners will closely collaborate to further strengthen the public-private partnership aiming to combat the worldwide growing problem of antimicrobial resistance. Read full press release.


172 Patients in EURECA

As of today COMBACTE-CARE's EURECA study has recruited a total of 172 patients. Currently twenty three sites have been initiated; in eight different countries (one center from Albania , Croatia, Kosovo, Montenegro, seven from Spain, five from Serbia, four from Turkey and three from Romania).

This month's top enrolling sites are Hospital Universitario Reina Sofia (Dr. De la Torre Cisneros), Spain, with 34 patients, Clinical Center of Serbia (Dr. Biljana Carevic), Serbia, with 34 patients and the Institute of Public Health of Vojvodina (Dr. Gorana Dragovac), Serbia, 29 patients.


EURECA is a very ambitious and challenging study involving 50 sites from 10 countries, aiming at including 2000 patients! All training sessions for participating sites have been done and completed by webcast; a recorded session will be also available for all participants in case they need a refresh some aspects. For those investigators who have not been able to attend the previous web sessions, an additional session will be organized towards the end of November.


Of course the study team in Seville and Antwerp are available for any questions by email and phone.





COMBACTE Country Visit, Bucharest, Romania

Duration: 2 Days

REANIMATION 2017, Paris, France

Duration: 2 Days
This research project receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115523 | 115620 | 115737 resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution.